An instrument to measure psychosocial determinants of health care professionals' vaccination behavior: Validation of the Pro-VC-Be questionnaire.


Journal

Expert review of vaccines
ISSN: 1744-8395
Titre abrégé: Expert Rev Vaccines
Pays: England
ID NLM: 101155475

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 4 3 2022
medline: 3 5 2022
entrez: 3 3 2022
Statut: ppublish

Résumé

The lack of validated instruments assessing vaccine hesitancy/confidence among health care professionals (HCPs) for themselves, and their patients led us to develop and validate the Pro-VC-Be instrument to measure vaccine confidence and other psychosocial determinants of HCPs' vaccination behavior among diverse HCPs in different countries. Cross-sectional survey in October-November 2020 among 1,249 GPs in France, 432 GPs in French-speaking parts of Belgium, and 1,055 nurses in Quebec (Canada), all participating in general population immunization. Exploratory and confirmatory factor analyses evaluated the instrument's construct validity. We used HCPs' self-reported vaccine recommendations to patients, general immunization activity, self-vaccination, and future COVID-19 vaccine acceptance to test criterion validity. The final results indicated a 6-factor structure with good fit: vaccine confidence (combining complacency, perceived vaccine risks, perceived benefit-risk balance, perceived collective responsibility), trust in authorities, perceived constraints, proactive efficacy (combining commitment to vaccination and self-efficacy), reluctant trust, and openness to patients. The instrument showed good convergent and criterion validity and adequate discriminant validity. This study found that the Pro-VC-Be is a valid instrument for measuring psychosocial determinants of HCPs' vaccination behaviors in different settings. Its validation is currently underway in Europe among various HCPs in different languages.

Identifiants

pubmed: 35238274
doi: 10.1080/14760584.2022.2046467
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-709

Auteurs

Pierre Verger (P)

Ors Paca, Southeastern Health Regional Observatory, Faculty of Medicine, Aix-Marseille University, Marseille, France.

Lisa Fressard (L)

Ors Paca, Southeastern Health Regional Observatory, Faculty of Medicine, Aix-Marseille University, Marseille, France.

Anna Soveri (A)

Institute of Clinical Medicine, University of Turku, Turku, Finland.

Nicolas Dauby (N)

Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Centre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), Brussel, Belgium.
Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussel, Belgium.

Angelo Fasce (A)

Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Linda Karlsson (L)

Institute of Clinical Medicine, University of Turku, Turku, Finland.

Stephan Lewandowsky (S)

School of Psychological Science, University of Bristol, Bristol, UK.
School of Psychological Science, University of Western Australia, Perth, Australia.

Philipp Schmid (P)

Media and Communication Science, University of Erfurt, Erfurt, Germany.

Eve Dubé (E)

Département d'Anthropologie, Faculté Des Sciences Sociales, Université Laval, Quebec, Canada.
Institut National de la Santé Publique du Québec, Quebec, Canada.
Centre de rechcerche du CHU de Québec, Université Laval, Quebec, Canada.

Arnaud Gagneur (A)

Department of Pediatrics, Centre de Recherche du CHUS, Sherbrooke, Canada.
Faculté de médecine et des sciences de la santé, Département de pédiatrie, Université de Sherbrooke-Campus de la Santé, Sherbrooke, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH